Get the Stockscreener App
1.55
7.19%
-0.12
After Hours:
1.54
-0.01
-0.65%
Sunshine Biopharma Inc stock is traded at $1.55, with a volume of 76,192.
It is down -7.19% in the last 24 hours and up +8.39% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$1.67
Open:
$1.66
24h Volume:
76,192
Relative Volume:
1.27
Market Cap:
$7.06M
Revenue:
$32.96M
Net Income/Loss:
$-4.23M
P/E Ratio:
-0.00998
EPS:
-155.3294
Net Cash Flow:
$-14.00M
1W Performance:
+1.31%
1M Performance:
+8.39%
6M Performance:
+12.32%
1Y Performance:
-49.35%
1-Day Range:
$1.50
$1.6607
1-Week Range:
$1.50
$1.76
52-Week Range:
$1.1693
$3.90
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.55 | 7.61M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Combining price and volume data for Sunshine Biopharma Inc.2025 Volatility Report & Weekly High Momentum Picks - newser.com
What technical models suggest about Sunshine Biopharma Inc.’s comebackPortfolio Risk Report & Risk Controlled Swing Trade Alerts - newser.com
Price momentum metrics for Sunshine Biopharma Inc. explainedLayoff News & Expert Approved Momentum Trade Ideas - newser.com
Has Sunshine Biopharma Inc. Equity Warrant found a price floorForecast Cut & AI Forecast Swing Trade Picks - newser.com
Sector ETF performance correlation with Sunshine Biopharma Inc.Market Trend Review & Free Reliable Trade Execution Plans - newser.com
How to forecast Sunshine Biopharma Inc. trends using time seriesMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Sunshine Biopharma develops new oral coronavirus inhibitors By Investing.com - Investing.com Canada
Using AI based signals to follow Sunshine Biopharma Inc. Equity Warrant2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Sunshine Biopharma develops new oral coronavirus inhibitors - Investing.com India
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections - ACCESS Newswire
Applying Wyckoff theory to Sunshine Biopharma Inc. Equity Warrant stockMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
What indicators show strength in Sunshine Biopharma Inc. Equity Warrant2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
Key resistance and support levels for Sunshine Biopharma Inc.Global Markets & Free Reliable Trade Execution Plans - newser.com
Sunshine Biopharma Inc. Equity Warrant stock volume spike explainedJuly 2025 Setups & Fast Entry High Yield Tips - newser.com
Sunshine Biopharma’s (SBFM) Sell (E+) Rating Reaffirmed at Weiss Ratings - Defense World
Real time breakdown of Sunshine Biopharma Inc. Equity Warrant stock performanceDollar Strength & Community Supported Trade Ideas - newser.com
Aegis Capital Reiterates Sunshine Biopharma (SBFM) Buy Recommendation - Nasdaq
Sunshine Biopharma (SBFM) Receives Reiterated 'Buy' Rating from Aegis Capital | SBFM Stock News - GuruFocus
What drives Sunshine Biopharma Inc Equity Warrant stock priceCurrency Fluctuation Impact & Double Digit Capital Growth - earlytimes.in
Institutional scanner results for Sunshine Biopharma Inc.July 2025 Price Swings & Expert Verified Movement Alerts - newser.com
Can technical indicators confirm Sunshine Biopharma Inc.’s reversal - newser.com
Market reaction to Sunshine Biopharma Inc. Equity Warrant’s recent newsMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
Is Sunshine Biopharma Inc. showing signs of accumulation2025 Market Overview & Community Consensus Stock Picks - newser.com
How sustainable is Sunshine Biopharma Inc. stock dividend payoutJuly 2025 Chart Watch & Advanced Technical Analysis Signals - newser.com
Does Sunshine Biopharma Inc. Equity Warrant qualify in momentum factor screeningWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Sunshine Biopharma Inc Equity Warrant Stock Analysis and ForecastAutomated Trading Signals & Capital Efficiency Improvement - earlytimes.in
Will Sunshine Biopharma Inc. Equity Warrant stock outperform value stocksWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Best data tools to analyze Sunshine Biopharma Inc. stockJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
What’s next for Sunshine Biopharma Inc. Equity Warrant stock priceEarnings Miss & Smart Allocation Stock Reports - newser.com
Is Sunshine Biopharma Inc. Equity Warrant stock supported by innovation pipelineJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Can Sunshine Biopharma Inc. Equity Warrant hit a new high this month2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
Multi factor analysis applied to Sunshine Biopharma Inc.July 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
Sunshine Biopharma (NASDAQ:SBFM) Shares Down 1.9% – Here’s What Happened - Defense World
Sunshine Biopharma Inc Stock Analysis and ForecastStock Screening Results & Calculate Profit Targets With AI Accuracy - earlytimes.in
What analysts say about Sunshine Biopharma Inc stockInterest Rate Changes & Identify Breakout Stocks - earlytimes.in
Using portfolio simulators with Sunshine Biopharma Inc. includedRate Cut & Daily Risk Controlled Trade Plans - newser.com
Sunshine Biopharma appoints M&K CPAS as new independent auditor By Investing.com - Investing.com South Africa
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):